BIRC3, an inhibitor of apoptosis protein by inhibiting caspases cascade, serves as a putative biomarker for patients with oesophageal adenocarcinoma (64) and is associated with therapeutic resistance in glioblastoma and breast cancer cells (65, 66). This evidence concerns the gene BIRC3 and esophageal adenocarcinoma.